| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/10/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 8.6% stake in Bionomics Limited |
| 07/13/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 11% stake in ASLAN Pharmaceuticals Limited |
| 06/06/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 6.1% stake in AVROBIO, Inc. |
| 06/01/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Bought 347,932 shares
@ $1.05, valued at
$365.3k
Bought 200,000 shares
@ $1, valued at
$200k
Bought 32,890 shares
@ $1.06, valued at
$34.9k
Bought 2,016 shares
@ $1.08, valued at
$2.2k
Bought 5,930 shares
@ $1.06, valued at
$6.3k
Bought 161,180 shares
@ $1.08, valued at
$174.1k
Bought 5,000 shares
@ $1.1, valued at
$5.5k
Bought 92,984 shares
@ $1.09, valued at
$101.4k
Bought 240,341 shares
@ $1.12, valued at
$269.2k
|
|
| 06/01/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on Rain Oncology Inc. |
| 06/01/2023 |
SC 13D
| TANG CAPITAL PARTNERS LP reports a 14.1% stake in Rain Oncology Inc. |
| 05/30/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Bought 50,000 shares
@ $1.72, valued at
$86k
|
|
| 05/15/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Bought 38,765 shares
@ $1.95, valued at
$75.6k
Bought 6,183 shares
@ $1.95, valued at
$12.1k
|
|
| 05/10/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Bought 57,073 shares
@ $1.95, valued at
$111.3k
Bought 20,141 shares
@ $1.95, valued at
$39.3k
Bought 6,774 shares
@ $1.95, valued at
$13.2k
|
|
| 05/05/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Bought 18,513 shares
@ $1.85, valued at
$34.2k
Bought 104,241 shares
@ $1.86, valued at
$193.9k
Bought 95,759 shares
@ $1.9, valued at
$181.9k
Bought 71,064 shares
@ $1.94, valued at
$137.9k
|
|
| 05/05/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on TCR2 THERAPEUTICS INC. |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/05/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/31/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 10% stake in Quince Therapeutics, Inc. |
| 03/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/17/2023 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 10.2% stake in Jounce Therapeutics, Inc. |
| 03/17/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 10% stake in Bellerophon Therapeutics, Inc. |
| 03/14/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Bought 65,701 shares
@ $0.994, valued at
$65.3k
Bought 20,286 shares
@ $1.018, valued at
$20.7k
|
|
| 03/14/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on Jounce Therapeutics, Inc. |
| 03/14/2023 |
SC 13D
| TANG CAPITAL PARTNERS LP reports a 10.2% stake in Jounce Therapeutics, Inc. |
| 03/13/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.3% stake in Adicet Bio, Inc. |
| 03/06/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 9.7% stake in Jounce Therapeutics, Inc. |
| 02/24/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.8% stake in Elevation Oncology, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in Corvus Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 5.3% stake in CytomX Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 3.2% stake in Heron Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in Inspirato Incorporated |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 9.4% stake in KalVista Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 10% stake in Metacrine, Inc. |
|